MarketCap
Facebook
X
TelegramCountry |
 Russia |
IPO year |
- |
Industry |
Biotechnology |
Stock Exchange |
MOEX |
Shares |
92.8 M |
Market Cap |
7.15 B |
EBITDA |
326 M |
P/E |
42.36 |
P/S |
5.23 |
EPS |
1.82 |
Other stocks of industry "Biotechnology"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Apellis Pharmaceuticals
APLS
|
$ 20.29 | -1.98 % | $ 2.56 B | Nasdaq Global Select Market,SPB |  USA |
 |
MorphoSys AG
MOR
|
- | 2.43 % | $ 254 M | Nasdaq Global Select Market |  Germany |
 |
Aptorum Group Limited
APM
|
$ 0.8 | -5.29 % | $ 4.36 M | Nasdaq Global Select Market |  China |
 |
Axsome Therapeutics
AXSM
|
$ 166.62 | 0.14 % | $ 8.29 B | Nasdaq Global Market,SPB | USA |
 |
I-Mab
IMAB
|
- | - | $ 866 M | Nasdaq Global Select Market | China |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
- | - | $ 40.3 B | Nasdaq Global Select Market | USA |
 |
Biophytis SA
BPTS
|
- | -13.47 % | $ 169 M | Nasdaq Capital Market |  France |
 |
AbCellera Biologics
ABCL
|
$ 3.76 | -1.7 % | $ 1.12 B | Nasdaq Global Select Market |  Canada |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
- | -1.52 % | $ 24.7 M | Nasdaq Capital Market | USA |
 |
Midatech Pharma plc
MTP
|
- | -18.52 % | $ 27.3 M | Nasdaq Global Select Market |  Britain |
 |
Burford Capital Limited
BUR
|
$ 8.45 | -3.26 % | $ 1.38 B | NYSE | Britain |
 |
Adverum Biotechnologies
ADVM
|
- | - | $ 86.2 M | Nasdaq Global Market | USA |
 |
ARCA biopharma
ABIO
|
- | 1052.0 % | $ 415 M | Nasdaq Capital Market | USA |
 |
Acer Therapeutics
ACER
|
- | 2.71 % | $ 14 M | Nasdaq Capital Market | USA |
 |
Alpine Immune Sciences
ALPN
|
- | - | $ 2.17 B | Nasdaq Global Market | USA |
 |
Acorda Therapeutics
ACOR
|
- | -24.86 % | $ 820 K | Nasdaq Global Select Market | USA |
 |
Capricor Therapeutics
CAPR
|
$ 25.77 | -4.06 % | $ 690 M | Nasdaq Capital Market | USA |
 |
Acasti Pharma
ACST
|
- | 4.01 % | $ 150 M | Nasdaq Capital Market | Canada |
 |
CureVac N.V.
CVAC
|
- | - | $ 867 M | Nasdaq Global Market | Germany |
 |
Aeterna Zentaris
AEZS
|
- | 5.93 % | $ 314 M | Nasdaq Capital Market | Canada |
 |
AgeX Therapeutics
AGE
|
- | -10.17 % | $ 12.2 K | NYSE American | USA |
 |
Codexis
CDXS
|
$ 0.97 | -5.15 % | $ 71.2 M | Nasdaq Global Select Market | USA |
 |
Aeglea BioTherapeutics
AGLE
|
- | - | $ 1.01 B | Nasdaq Global Market | USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
- | - | $ 26.5 M | Nasdaq Global Select Market | USA |
 |
AIkido Pharma
AIKI
|
- | 1.93 % | $ 17.4 M | Nasdaq Capital Market | USA |
 |
Agenus
AGEN
|
$ 3.15 | -5.69 % | $ 1.13 M | Nasdaq Capital Market | USA |
 |
Ayala Pharmaceuticals
AYLA
|
- | - | $ 7.46 M | Nasdaq Global Market |  Israel |
 |
Akero Therapeutics
AKRO
|
- | - | $ 3.67 B | Nasdaq Global Select Market,SPB | USA |
 |
Agios Pharmaceuticals
AGIO
|
$ 28.45 | -2.57 % | $ 1.65 B | Nasdaq Global Select Market,SPB | USA |
 |
Advaxis
ADXS
|
- | -9.65 % | $ 45.9 M | Nasdaq Capital Market | USA |
 |
Akouos
AKUS
|
- | 0.23 % | $ 488 M | Nasdaq Global Select Market | USA |
 |
Завод ДИОД
DIOD
|
- | - | - | MOEX,SPB | Russia |
 |
Фармсинтез
LIFE
|
- | - | - | MOEX | Russia |
 |
Albireo Pharma
ALBO
|
- | -0.23 % | $ 916 M | Nasdaq Capital Market | USA |
 |
Cellectis S.A.
CLLS
|
$ 3.65 | -3.95 % | $ 116 M | Nasdaq Global Market | France |
 |
Alector
ALEC
|
$ 2.1 | -5.2 % | $ 216 M | Nasdaq Global Select Market,SPB | USA |
 |
Allena Pharmaceuticals
ALNA
|
- | 3.16 % | $ 1.9 M | Nasdaq Global Select Market | USA |
 |
Aileron Therapeutics
ALRN
|
- | 10.36 % | $ 9.8 M | Nasdaq Global Select Market | USA |
 |
Altimmune
ALT
|
$ 4.16 | -0.12 % | $ 295 M | Nasdaq Global Market | USA |
 |
Teligent, Inc.
TLGT
|
- | -13.85 % | $ 16.1 M | Nasdaq Global Select Market | USA |
 |
AlloVir
ALVR
|
- | 4.14 % | $ 49.1 M | Nasdaq Global Select Market | USA |
 |
Viela Bio, Inc.
VIE
|
- | - | $ 2.91 B | Nasdaq Global Select Market | USA |
 |
Ampio Pharmaceuticals
AMPE
|
- | -11.43 % | $ 502 K | NYSE American | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
$ 23.99 | 0.46 % | $ 2.93 B | Nasdaq Capital Market | USA |
 |
Amarin Corporation plc
AMRN
|
$ 13.89 | -0.32 % | $ 5.76 B | Nasdaq Global Market |  Irlanda |
 |
AbbVie
ABBV
|
$ 231.88 | -1.0 % | $ 410 B | NYSE,SPB | USA |
 |
Blueprint Medicines Corporation
BPMC
|
- | - | $ 8.14 B | Nasdaq Global Select Market,SPB | USA |
 |
Applied Molecular Transport
AMTI
|
- | - | $ 10.1 M | Nasdaq Global Select Market,SPB | USA |
 |
AIM ImmunoTech
AIM
|
$ 0.71 | -8.96 % | $ 34.1 M | NYSE American | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.